NuvinkaDx Achieves Milestones for GeneProof and ALPCO's Diagnostic Solutions NuvinkaDx announces groundbreaking achievements for its companies GeneProof and ALPCO, enhancing diagnostic testing capabilities in Europe and Canada.

NuvinkaDx Achieves Milestones for GeneProof and ALPCO's Diagnostic Solutions #United_States #Salem #ALPCO #NuvinkaDx #GeneProof

ALPCO Launches Innovative Calprotectin Assay and Begins Clinical Trials in the US ALPCO expands its GI diagnostic solutions with the European launch of a Calprotectin assay, and initiates a clinical trial for a new automated version in the US, enhancing diagnostic accuracy.

ALPCO Launches Innovative Calprotectin Assay and Begins Clinical Trials in the US #United_States #Salem #Calprotectin_Assay #ALPCO #NuvinkaDx